Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 457.0
(-2.35%)
JPY 457.0
(-2.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.66 Billion JPY | 46.65% |
| 2022 | 1.13 Billion JPY | -9.47% |
| 2021 | 1.25 Billion JPY | 8.51% |
| 2020 | 1.15 Billion JPY | -2.62% |
| 2019 | 1.18 Billion JPY | -7.52% |
| 2018 | 1.28 Billion JPY | -5.08% |
| 2017 | 1.35 Billion JPY | 10.57% |
| 2016 | 1.22 Billion JPY | 111.43% |
| 2015 | 578.95 Million JPY | 9.75% |
| 2014 | 527.52 Million JPY | 10.96% |
| 2013 | 475.41 Million JPY | 241.08% |
| 2012 | 139.38 Million JPY | 99.64% |
| 2011 | 69.81 Million JPY | 706.53% |
| 2010 | -11.51 Million JPY | -170.74% |
| 2009 | 16.27 Million JPY | 51.46% |
| 2008 | 10.74 Million JPY | -9.55% |
| 2007 | 11.87 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 247.09 Million JPY | -49.36% |
| 2024 Q2 | 424.46 Million JPY | 71.78% |
| 2023 Q1 | 460.35 Million JPY | 34.84% |
| 2023 Q2 | 364.25 Million JPY | -20.88% |
| 2023 FY | 1.66 Billion JPY | 46.65% |
| 2023 Q3 | 354.22 Million JPY | -2.75% |
| 2023 Q4 | 487.95 Million JPY | 37.75% |
| 2022 FY | 1.13 Billion JPY | -9.47% |
| 2022 Q1 | 237.29 Million JPY | -12.28% |
| 2022 Q2 | 296.24 Million JPY | 24.84% |
| 2022 Q3 | 261.66 Million JPY | -11.67% |
| 2022 Q4 | 341.39 Million JPY | 30.47% |
| 2021 Q2 | 291.7 Million JPY | -4.04% |
| 2021 FY | 1.25 Billion JPY | 8.51% |
| 2021 Q1 | 303.98 Million JPY | -29.64% |
| 2021 Q3 | 389.28 Million JPY | 33.45% |
| 2021 Q4 | 270.5 Million JPY | -30.51% |
| 2020 Q3 | 241.9 Million JPY | -16.29% |
| 2020 Q2 | 288.99 Million JPY | 48.93% |
| 2020 Q1 | 194.04 Million JPY | -58.94% |
| 2020 FY | 1.15 Billion JPY | -2.62% |
| 2020 Q4 | 432.02 Million JPY | 78.6% |
| 2019 FY | 1.18 Billion JPY | -7.52% |
| 2019 Q3 | 262.57 Million JPY | -4.14% |
| 2019 Q2 | 273.89 Million JPY | 52.97% |
| 2019 Q1 | 179.05 Million JPY | -61.64% |
| 2019 Q4 | 472.63 Million JPY | 80.0% |
| 2018 Q3 | 262.44 Million JPY | -25.15% |
| 2018 FY | 1.28 Billion JPY | -5.08% |
| 2018 Q1 | 204.94 Million JPY | -50.04% |
| 2018 Q2 | 350.61 Million JPY | 71.08% |
| 2018 Q4 | 466.75 Million JPY | 77.85% |
| 2017 Q3 | 311.35 Million JPY | -10.89% |
| 2017 Q2 | 349.38 Million JPY | 23.66% |
| 2017 FY | 1.35 Billion JPY | 10.57% |
| 2017 Q1 | 282.54 Million JPY | -60.41% |
| 2017 Q4 | 410.23 Million JPY | 31.76% |
| 2016 FY | 1.22 Billion JPY | 111.43% |
| 2016 Q4 | 713.6 Million JPY | 324.49% |
| 2016 Q3 | 168.1 Million JPY | -7.08% |
| 2016 Q2 | 180.91 Million JPY | 12.06% |
| 2016 Q1 | 161.44 Million JPY | -27.28% |
| 2015 Q2 | 151.16 Million JPY | 21.09% |
| 2015 Q3 | 80.95 Million JPY | -46.44% |
| 2015 Q4 | 222 Million JPY | 174.21% |
| 2015 FY | 578.95 Million JPY | 9.75% |
| 2015 Q1 | 124.83 Million JPY | -51.47% |
| 2014 Q2 | 6.38 Million JPY | -95.18% |
| 2014 Q4 | 257.21 Million JPY | 95.78% |
| 2014 FY | 527.52 Million JPY | 10.96% |
| 2014 Q1 | 132.54 Million JPY | -27.84% |
| 2014 Q3 | 131.38 Million JPY | 1958.3% |
| 2013 Q3 | 121.55 Million JPY | 86.0% |
| 2013 Q1 | 104.82 Million JPY | 183.64% |
| 2013 FY | 475.41 Million JPY | 241.08% |
| 2013 Q4 | 183.68 Million JPY | 51.12% |
| 2013 Q2 | 65.35 Million JPY | -37.66% |
| 2012 Q1 | 15 Million JPY | -44.55% |
| 2012 FY | 139.38 Million JPY | 99.64% |
| 2012 Q4 | 36.95 Million JPY | -12.73% |
| 2012 Q3 | 42.34 Million JPY | -6.05% |
| 2012 Q2 | 45.07 Million JPY | 200.47% |
| 2011 FY | 69.81 Million JPY | 706.53% |
| 2011 Q1 | 42.25 Million JPY | 228.99% |
| 2011 Q4 | 27.05 Million JPY | 9326.13% |
| 2011 Q3 | 287 Thousand JPY | 28.7% |
| 2011 Q2 | 223 Thousand JPY | -99.47% |
| 2010 Q1 | -14.3 Million JPY | -440.3% |
| 2010 Q3 | -7.3 Million JPY | -165.96% |
| 2010 Q4 | 12.84 Million JPY | 275.8% |
| 2010 Q2 | -2.74 Million JPY | 80.79% |
| 2010 FY | -11.51 Million JPY | -170.74% |
| 2009 FY | 16.27 Million JPY | 51.46% |
| 2009 Q3 | -2.47 Million JPY | -113.91% |
| 2009 Q2 | 17.78 Million JPY | 648.83% |
| 2009 Q1 | -3.24 Million JPY | -160.02% |
| 2009 Q4 | 4.2 Million JPY | 269.96% |
| 2008 FY | 10.74 Million JPY | -9.55% |
| 2008 Q3 | 1.54 Million JPY | -17.92% |
| 2008 Q2 | 1.88 Million JPY | -2.08% |
| 2008 Q1 | 1.92 Million JPY | 0.0% |
| 2008 Q4 | 5.39 Million JPY | 249.61% |
| 2007 FY | 11.87 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 11.402% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1975.541% |
| GNI Group Ltd. | 22.43 Billion JPY | 92.569% |
| Linical Co., Ltd. | 3.77 Billion JPY | 55.885% |
| Trans Genic Inc. | 2.24 Billion JPY | 25.896% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -1596.438% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 32.855% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -28.947% |
| AnGes, Inc. | -3.06 Billion JPY | 154.376% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 1037.881% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 82.753% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -222.213% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -1402.203% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -14.903% |
| CanBas Co., Ltd. | -984 Million JPY | 269.389% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -325.528% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -0.642% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -318.165% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -60.363% |
| PeptiDream Inc. | 17.21 Billion JPY | 90.32% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -5346.117% |
| Ribomic Inc. | -10.5 Million JPY | 15971.11% |
| SanBio Company Limited | -14.5 Million JPY | 11591.892% |
| Healios K.K. | 108 Million JPY | -1443.319% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 488892.962% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 2922.857% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 110337.037% |
| StemRIM | -44.34 Million JPY | 3858.335% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 47.668% |
| FunPep Company Limited | -680.28 Million JPY | 345.012% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -2306.908% |
| Stella Pharma Corporation | 217.29 Million JPY | -667.05% |
| TMS Co., Ltd. | -6.95 Million JPY | 24082.504% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -429.876% |
| Cuorips Inc. | 9.63 Million JPY | -17206.448% |
| K Pharma,Inc. | 910 Million JPY | -83.163% |
| Takara Bio Inc. | 25.45 Billion JPY | 93.453% |
| ReproCELL Incorporated | 1.1 Billion JPY | -50.878% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -39.473% |
| StemCell Institute Inc. | 1.57 Billion JPY | -5.768% |
| CellSeed Inc. | 107.15 Million JPY | -1455.489% |